Segal J L, Gray D R, Gordon S K, Eltorai I M, Khonsari F, Patel J
Paraplegia. 1985 Feb;23(1):47-55. doi: 10.1038/sc.1985.8.
The disposition kinetics of gentamicin, an aminoglycoside antibiotic, were studied in seven tetraplegic and six paraplegic volunteers. The volume of distribution of gentamicin in l/kg of body weight varied in a statistically significant way from values of this parameter measured in normal subjects. The elimination of gentamicin in spinal man proceeded in a log-linear fashion accurately characterized by a one compartment open-model with a half-life of approximately 2 hours. The clinical significance of altered disposition kinetics and an increased intersubject variability in gentamicin disposition in spinal man as compared to normal subjects is unknown. The existence of these observed differences in pharmacokinetic parameters, however, emphasizes the need to define individual pharmacokinetic profiles and individualize dosing regimens in spinal man. The data presented are supportive of the hypothesis that spinal man constitutes a discreet therapeutic population.
在七名四肢瘫痪和六名截瘫志愿者中研究了氨基糖苷类抗生素庆大霉素的处置动力学。以每千克体重升为单位的庆大霉素分布容积与在正常受试者中测得的该参数值相比,存在统计学上的显著差异。脊髓损伤患者体内庆大霉素的消除呈对数线性方式,可用单室开放模型精确描述,半衰期约为2小时。与正常受试者相比,脊髓损伤患者庆大霉素处置动力学改变及个体间变异性增加的临床意义尚不清楚。然而,这些观察到的药代动力学参数差异的存在强调了在脊髓损伤患者中确定个体药代动力学特征并个体化给药方案的必要性。所呈现的数据支持脊髓损伤患者构成一个独立治疗群体的假设。